Negev Labs
Biotechnology Research
Disorders Where Conventional Treatments Fall Short—including #parkinson’s
7 employees
- Employees
- 7
- Contacts
- 3
- Emails
- 3
- Phones
- 1
Negev Labs Overview
- Headquarters
- Disorders Where Conventional Treatments Fall Short—including #parkinson’s
- Website
- negevlabs.com
- Industry
- Biotechnology Research
- Employees
- 7
- Founded
- 2022
- Funding
- 2025
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About Negev Labs
Negev Labs is a pioneering biopharma company builder focused on developing next-generation, non-hallucinogenic neuroplastogens—innovative therapies derived from psychedelic compounds designed to enhance energy, focus, and overall well-being without the side effects of traditional medications.
Negev Labs Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
- Phone contacts
- 1
- 25.0% coverage
Negev Labs Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Sa'ar Yaniv | Strategic Business & Corporate | New York, United States |
Email
Phone
|
| Ken Belotsky | Partner @ Negev Capital - Co-founder @ |
View
|
|
| Kostia Adamsky | Center District, Israel |
Email
|
|
| Daniel Jeffries, Ph.d. | Pharmaceutical Development Strategy | Greater Boston, United States |
Email
|
Employees by Management Level
Individual contributor
2 profiles
Executive
1 profile
Compare Similar Companies to Negev Labs
Angelini Pharma
Pharmaceutical Manufacturing
nChroma Bio
Biotechnology Research
Angitia Biopharmaceuticals
Biotechnology Research
Gilgamesh Pharmaceuticals
Pharmaceutical Manufacturing
Xylo Bio
Biotechnology
Bright Box
It Services And It Consulting
Eleusis
Biotechnology Research
Nimble Therapeutics
Biotechnology Research
Psilera
Biotechnology Research
Negev Capital
Venture Capital And Private Equity Principals